Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Expert discussion of targeted therapy for early stage lung cancer from Roy Herbst at NYLCF26. ADAURA with adjuvant osimertinib established the paradigm.
Apart from expanding to different subtypes, what is next? Need answers on duration and MRD to guide proper use.”
Other articles featuring Stephen V Liu on OncoDaily.
